(BMY) |
| 0 (0%) 06-03 15:46 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 60.78 |
| Resistance 1: | 58.27 |
| Pivot price: | 57.15 |
| Support 1: | 54.20 |
| Support 2: | 45.09 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 3.570 |
| Book Value | 9.830 |
| PEG Ratio | 180.38 |
| Gross Profit | 17.108 |
| Profit Margin (%) | 15.01 |
| Operating Margin (%) | 33.04 |
| Return on Assets (ttm) | 10.7 |
| Return on Equity (ttm) | 38.7 |
Company news
Wed, 03 Jun 2026
BMY Collaborates with Arcus Biosciences on Clinical Trial for Ca - GuruFocus
Wed, 03 Jun 2026
Bristol Myers Squibb Company (BMY) is attracting investor attention: Here is what you should know - MSN
Wed, 03 Jun 2026
Westpac Banking Corp Purchases 46,386 Shares of Bristol Myers Squibb Company $BMY - MarketBeat
Wed, 03 Jun 2026
Bristol Myers Squibb (BMY) Is Down 6.2% After EU Opdivo Frontline Hodgkin Lymphoma Approval - What's Changed - simplywall.st
Wed, 03 Jun 2026
Bank of New York Mellon Corp Has $1.32 Billion Stock Position in Bristol Myers Squibb Company $BMY - MarketBeat
Tue, 02 Jun 2026
Why Is SMMT Stock Surging Over 10% In Overnight Trading? - Stocktwits
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
